Stockscreener 앱 받기
11.24
5.70%
-0.68
시간 외 거래:
11.00
-0.24
-2.14%
Zenas Biopharma Inc 주식(ZBIO)의 최신 뉴스
Cohen Milstein Reminds Zenas BioPharma (ZBIO) Investors of Opportunity to Lead Securities Fraud Suit - GlobeNewswire
Cohen Milstein Reminds Zenas BioPharma (ZBIO) Investors of Opportunity to Lead Securities Fraud Suit - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming DeadlinesZBIO - TradingView
Bullish Zenas BioPharma Insiders Loaded Up On US$2.11m Of Stock - simplywall.st
The Gross Law Firm Notifies Shareholders of Zenas BioPharma, Inc.(ZBIO) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - StreetInsider
ZBIO LAWSUIT ALERT: Levi & Korsinsky Notifies Zenas BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Shareholders of Zenas BioPharma, Inc. Should Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your RightsZBIO - PR Newswire
Cohen Milstein Seeks Investors to Lead Suit to Hold Zenas BioPharma (ZBIO) Accountable for IPO-Related Fraud - GlobeNewswire
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors - GlobeNewswire
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025 – ZBIO - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - StreetInsider
Robbins LLP Reminds ZBIO Stockholders with Large Losses to Contact the Law Firm for Information - Bluefield Daily Telegraph
Robbins LLP Reminds ZBIO Stockholders with Large Losses to - GlobeNewswire
Robbins LLP Reminds ZBIO Stockholders with Large Losses to Contact the Law Firm for Information on Leading the Zenas BioPharma, Inc. Class Action - TradingView
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Lawsuit Filed by The Rosen Law Firm - PR Newswire
ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
ZBIO Investor Reminder: Cohen Milstein Encourages Zenas - GlobeNewswire
Zenas BioPharma, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before June 16, 2025 to Discuss Your RightsZBIO - Morningstar
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
ROSEN, THE FIRST FILING FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel - Bluefield Daily Telegraph
ROSEN, THE FIRST FILING FIRM, Encourages Zenas BioPharma, - GlobeNewswire
The Gross Law Firm Notifies Zenas BioPharma, Inc. Investors of a Class Action Lawsuit and ... - Bluefield Daily Telegraph
Zenas Biopharma director Xiao Ting buys $77,600 in stock - Investing.com
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
Zenas BioPharma, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before June 16, 2025 to Discuss Your RightsZBIO - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - GlobeNewswire
Zenas BioPharma Investors Encouraged to Contact Cohen - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas - Bluefield Daily Telegraph
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zenas - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Zenas BioPharma, Inc.(ZBIO) Shareholders - marketscreener.com
Zenas Biopharma (ZBIO) vs. Its Peers Head to Head Review - Defense World
Cohen Milstein Seeks Investors Willing to Lead Zenas BioPharma (ZBIO) Securities Fraud Class Action - GlobeNewswire
ZBIO LAWSUIT ALERT: Levi & Korsinsky Notifies Zenas - GlobeNewswire
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Zenas BioPharma, Inc. (NASDAQ - Bluefield Daily Telegraph
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Zenas BioPharma, Inc. (NASDAQ: ZBIO); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - GlobeNewswire
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed - GlobeNewswire
ZBIO LAWSUIT ALERT: Levi & Korsinsky Notifies Zenas BioPharma, Inc. Investors of a Class - Bluefield Daily Telegraph
The Gross Law Firm Notifies Zenas BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineZBIO - PR Newswire
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ZBIO LAWSUIT ALERT: The Gross Law Firm Notifies Zenas BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TradingView
ZBIO LAWSUIT ALERT: The Gross Law Firm Notifies Zenas BioPharma, Inc. Investors of a Class - Bluefield Daily Telegraph
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - Morningstar
Zenas BioPharma Insiders US$407k Short Of Breakeven On Stock Purchase - Yahoo Finance
Cohen Milstein Calls on Zenas BioPharma (ZBIO) Investors to Act Following Significant Post-IPO Losses - GlobeNewswire
ZBIO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Lawsuit filed for Investors who lost money with shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) - openPR.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel - Bluefield Daily Telegraph
ROSEN, A LONGSTANDING LAW FIRM, Encourages Zenas BioPharma, - GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – ZBIO - TradingView
0.39%
3.66%
자본화:
|
볼륨(24시간):